5 results

• Judge Clears BioZorb Breast Marker Lawsuit To Move Forward, Rejecting Motion for Summary Judgment

  January 9, 2025

  Irvin Jackson

  In a ruling likely to apply broadly across the litigation, a federal judge is refusing to dismiss a BioZorb marker lawsuit, clearing the way for other claims to move forward.

• Hologic Seeks To Dismiss BioZorb Design Defect Claims in Lawsuits Over Recalled Tissue Marker

  November 14, 2024

  Irvin Jackson

  Although a BioZorb recall has been issued for all versions of the breast tissue markers sold by Hologic, the manufacturer is asking a federal judge to throw out lawsuits alleging that injuries were caused by design defects.

• Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects

  September 4, 2024

  Irvin Jackson

  Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.

• BioZorb Injury Lawsuits Are Being Prepared For Trial in July 2025 in District of Massachusetts

  August 14, 2024

  Irvin Jackson

  A group of four lawsuits over the BioZorb marker will be selected for a series of early bellwether trial dates starting in July 2025, which are designed to help gauge how juries may respond to evidence that will be repeated throughout claims that the tissue marker caused painful complication.

• BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal

  July 11, 2024

  Russell Maas

  A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.